Results 151 to 160 of about 5,127,009 (325)

Rational Development of a Novel Emulgel Adjuvant for Single‐Shot Effective Vaccination: A Multivariate Analysis Approach

open access: yesAdvanced Materials, EarlyView.
Using multivariate analysis, a novel emulgel adjuvant is developed by combining key nanoemulsion formulation variables–hydrogel trapping, small globule size, and mannide monooleate surfactant–achieving 10× greater immunogenicity than MF59 in mice after a single shot.
Ahmed O. Shalash   +9 more
wiley   +1 more source

Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait

open access: yesEClinicalMedicine, 2020
Background: In Kuwait, prior to the first case of COVID-19 being reported in the country, mass screening of incoming travelers from countries with known outbreaks was performed and resulted in the first identified cases in the country. All COVID-19 cases
Sulaiman Almazeedi   +6 more
doaj  

A ODISSEIA DE UMA ALFABETIZADORA EM TEMPOS DE PANDEMIA DA COVID-19

open access: bronze, 1969
Gabriela Medeiros Nogueira   +3 more
openalex   +2 more sources

Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas

open access: yesAdvanced Materials, EarlyView.
ENDO lipid nanoparticles containing cholecalciferol as a fifth component demonstrate mRNA delivery to the pancreas with 99% selectivity, including beta cells. This platform shows minimal toxicity and sustained protein expression for up to 3 days in a dose‐dependent manner, offering a novel approach to pancreas‐specific mRNA delivery and gene therapy ...
Ivan Isaac   +7 more
wiley   +1 more source

NARRATIVAS DE GESTORES ESCOLARES DE ESCOLAS DO CAMPO EM TEMPO DE PANDEMIA DE COVID-19

open access: bronze, 1969
Darciel Pasinato   +2 more
openalex   +2 more sources

Advances and Strategies in Enhancing mRNA Cancer Vaccines

open access: yesAdvanced Materials, EarlyView.
Messenger RNA (mRNA) vaccines offer a powerful approach for cancer immunotherapy, but their clinical impact remains limited by delivery challenges and suboptimal immune activation. This review discusses key biological barriers and design strategies—including structural optimization, immunomodulation, organ targeting delivery, and advanced nanocarriers ...
Miao Zhang   +4 more
wiley   +1 more source

Temporal dynamics in viral shedding and transmissibility of COVID-19

open access: yesNature Network Boston, 2020
Xi He   +22 more
semanticscholar   +1 more source

Artificial Intelligence‐Driven Nanoarchitectonics for Smart Targeted Drug Delivery

open access: yesAdvanced Materials, EarlyView.
This perspective introduces an artificial intelligence (AI)‐driven nanoarchitectonics framework for targeted drug delivery, combining database‐guided nanocarrier design, machine learning (ML)‐assisted surface engineering with a designed targeting system, and in silico modeling for dynamic optimization.
Hayeon Bae   +6 more
wiley   +1 more source

The anesthesiologist and COVID-19

open access: yesBrazilian Journal of Anesthesiology (English Edition), 2020
Quintão, Vinícius Caldeira   +9 more
openaire   +9 more sources

Home - About - Disclaimer - Privacy